Effect of creatine supplementation on oxygen uptake kinetics during submaximal cycle exercise.
The purpose of this study was to test the effect of oral creatine (Cr) supplementation on pulmonary oxygen uptake (VO(2)) kinetics during moderate [below ventilatory threshold (VT)] and heavy (above VT) submaximal cycle exercise. Nine subjects (7 men; means +/- SD: age 28 +/- 3 yr, body mass 73.2 +/- 5.6 kg, maximal VO(2) 46.4 +/- 8.0 ml. kg(-1). min(-1)) volunteered to participate in this study. Subjects performed transitions of 6-min duration from unloaded cycling to moderate (80% VT; 8-12 repeats) and heavy exercise (50% change; i.e., halfway between VT and maximal VO(2); 4-6 repeats), both in the control condition and after Cr loading, in a crossover design. The Cr loading regimen involved oral consumption of 20 g/day of Cr monohydrate for 5 days, followed by a maintenance dose of 5 g/day thereafter. VO(2) was measured breath by breath and modeled by using two (moderate) or three (heavy) exponential terms. For moderate exercise, there were no differences in the parameters of the VO(2) kinetic response between control and Cr-loaded conditions. For heavy exercise, the time-based parameters of the VO(2) response were unchanged, but the amplitude of the primary component was significantly reduced with Cr loading (means +/- SE: control 2.00 +/- 0.12 l/min; Cr loaded 1.92 +/- 0.10 l/min; P < 0.05) as was the end-exercise VO(2) (control 2.19 +/- 0.13 l/min; Cr loaded 2.12 +/- 0.14 l/min; P < 0.05). The magnitude of the reduction in submaximal VO(2) with Cr loading was significantly correlated with the percentage of type II fibers in the vastus lateralis (r = 0.87; P < 0.01; n = 7), indicating that the effect might be related to changes in motor unit recruitment patterns or the volume of muscle activated.
Jones
Andrew M
AM
Department of Exercise and Sport Science, Manchester Metropolitan University, Alsager ST7 2HL, United Kingdom. a.m.jones@mmu.ac.kr
Carter
Helen
H
Pringle
Jamie S M
JS
Campbell
Iain T
IT
D000284:Administration, Oral; D000328:Adult; D001642:Bicycling; D003401:Creatine / Q000008:administration & dosage / Q000494:pharmacology*; D018592:Cross-Over Studies; D004056:Differential Threshold; D015444:Exercise / Q000502:physiology*; D005260:Female; D006801:Humans; D007700:Kinetics; D008297:Male; D010101:Oxygen Consumption / Q000187:drug effects; D005082:Physical Exertion / Q000502:physiology; D012119:Respiration
D003401:Creatine